Ipsen S.A.
Ipsen S.A. IPSEY Peers
See (IPSEY) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| IPSEY | $33.00 | +1.79% | 43.7B | 26.61 | $1.24 | +0.79% |
| MKGAF | $137.00 | +1.84% | 59.6B | 18.00 | $7.61 | +1.83% |
| MKKGY | $26.81 | +0.07% | 57.6B | 17.71 | $1.51 | +1.87% |
| TKPHF | $29.50 | -8.19% | 46.4B | 65.56 | $0.45 | +4.51% |
| HLNCF | $4.93 | +1.02% | 44.2B | 23.45 | $0.21 | +1.77% |
| SDZNY | $60.23 | +0.57% | 26B | -3015.50 | -$0.02 | +1.12% |
| ESALY | $61.51 | -2.11% | 17.6B | 20.54 | $3.00 | N/A |
| TEVJF | $14.00 | +0.00% | 16.1B | -12.17 | -$1.15 | N/A |
| SGIOY | $8.57 | +0.23% | 14.6B | 12.79 | $0.67 | +1.85% |
| SGIOF | $16.20 | +0.00% | 13.8B | 12.00 | $1.35 | +2.57% |
Stock Comparison
IPSEY vs MKGAF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, MKGAF has a market cap of 59.6B. Regarding current trading prices, IPSEY is priced at $33.00, while MKGAF trades at $137.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas MKGAF's P/E ratio is 18.00. In terms of profitability, IPSEY's ROE is +0.17%, compared to MKGAF's ROE of +0.10%. Regarding short-term risk, IPSEY is less volatile compared to MKGAF. This indicates potentially lower risk in terms of short-term price fluctuations for IPSEY.
IPSEY vs MKKGY Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, MKKGY has a market cap of 57.6B. Regarding current trading prices, IPSEY is priced at $33.00, while MKKGY trades at $26.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas MKKGY's P/E ratio is 17.71. In terms of profitability, IPSEY's ROE is +0.17%, compared to MKKGY's ROE of +0.10%. Regarding short-term risk, IPSEY is less volatile compared to MKKGY. This indicates potentially lower risk in terms of short-term price fluctuations for IPSEY.
IPSEY vs TKPHF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, TKPHF has a market cap of 46.4B. Regarding current trading prices, IPSEY is priced at $33.00, while TKPHF trades at $29.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas TKPHF's P/E ratio is 65.56. In terms of profitability, IPSEY's ROE is +0.17%, compared to TKPHF's ROE of +0.01%. Regarding short-term risk, IPSEY and TKPHF have similar daily volatility (0.00).
IPSEY vs HLNCF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, HLNCF has a market cap of 44.2B. Regarding current trading prices, IPSEY is priced at $33.00, while HLNCF trades at $4.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas HLNCF's P/E ratio is 23.45. In terms of profitability, IPSEY's ROE is +0.17%, compared to HLNCF's ROE of +0.09%. Regarding short-term risk, IPSEY is less volatile compared to HLNCF. This indicates potentially lower risk in terms of short-term price fluctuations for IPSEY.
IPSEY vs SDZNY Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, SDZNY has a market cap of 26B. Regarding current trading prices, IPSEY is priced at $33.00, while SDZNY trades at $60.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas SDZNY's P/E ratio is -3015.50. In terms of profitability, IPSEY's ROE is +0.17%, compared to SDZNY's ROE of +0.00%. Regarding short-term risk, IPSEY is less volatile compared to SDZNY. This indicates potentially lower risk in terms of short-term price fluctuations for IPSEY.
IPSEY vs ESALY Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, ESALY has a market cap of 17.6B. Regarding current trading prices, IPSEY is priced at $33.00, while ESALY trades at $61.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas ESALY's P/E ratio is 20.54. In terms of profitability, IPSEY's ROE is +0.17%, compared to ESALY's ROE of +0.06%. Regarding short-term risk, IPSEY is less volatile compared to ESALY. This indicates potentially lower risk in terms of short-term price fluctuations for IPSEY.
IPSEY vs TEVJF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, TEVJF has a market cap of 16.1B. Regarding current trading prices, IPSEY is priced at $33.00, while TEVJF trades at $14.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas TEVJF's P/E ratio is -12.17. In terms of profitability, IPSEY's ROE is +0.17%, compared to TEVJF's ROE of -0.21%. Regarding short-term risk, IPSEY is less volatile compared to TEVJF. This indicates potentially lower risk in terms of short-term price fluctuations for IPSEY.
IPSEY vs SGIOY Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, SGIOY has a market cap of 14.6B. Regarding current trading prices, IPSEY is priced at $33.00, while SGIOY trades at $8.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas SGIOY's P/E ratio is 12.79. In terms of profitability, IPSEY's ROE is +0.17%, compared to SGIOY's ROE of +0.05%. Regarding short-term risk, IPSEY is less volatile compared to SGIOY. This indicates potentially lower risk in terms of short-term price fluctuations for IPSEY.
IPSEY vs SGIOF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, SGIOF has a market cap of 13.8B. Regarding current trading prices, IPSEY is priced at $33.00, while SGIOF trades at $16.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas SGIOF's P/E ratio is 12.00. In terms of profitability, IPSEY's ROE is +0.17%, compared to SGIOF's ROE of +0.05%. Regarding short-term risk, IPSEY and SGIOF have similar daily volatility (0.00).
IPSEY vs BIOVF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, BIOVF has a market cap of 10.3B. Regarding current trading prices, IPSEY is priced at $33.00, while BIOVF trades at $29.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas BIOVF's P/E ratio is 22.57. In terms of profitability, IPSEY's ROE is +0.17%, compared to BIOVF's ROE of +0.10%. Regarding short-term risk, IPSEY and BIOVF have similar daily volatility (0.00).
IPSEY vs IPSEF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, IPSEF has a market cap of 9.4B. Regarding current trading prices, IPSEY is priced at $33.00, while IPSEF trades at $113.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas IPSEF's P/E ratio is 22.67. In terms of profitability, IPSEY's ROE is +0.17%, compared to IPSEF's ROE of +0.14%. Regarding short-term risk, IPSEY is less volatile compared to IPSEF. This indicates potentially lower risk in terms of short-term price fluctuations for IPSEY.
IPSEY vs ESAIY Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, ESAIY has a market cap of 8B. Regarding current trading prices, IPSEY is priced at $33.00, while ESAIY trades at $7.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas ESAIY's P/E ratio is 25.25. In terms of profitability, IPSEY's ROE is +0.17%, compared to ESAIY's ROE of +0.03%. Regarding short-term risk, IPSEY is less volatile compared to ESAIY. This indicates potentially lower risk in terms of short-term price fluctuations for IPSEY.
IPSEY vs SFOSF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, SFOSF has a market cap of 7.6B. Regarding current trading prices, IPSEY is priced at $33.00, while SFOSF trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas SFOSF's P/E ratio is 13.03. In terms of profitability, IPSEY's ROE is +0.17%, compared to SFOSF's ROE of +0.06%. Regarding short-term risk, IPSEY is less volatile compared to SFOSF. This indicates potentially lower risk in terms of short-term price fluctuations for IPSEY.
IPSEY vs ESALF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, ESALF has a market cap of 7.2B. Regarding current trading prices, IPSEY is priced at $33.00, while ESALF trades at $25.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas ESALF's P/E ratio is 23.26. In terms of profitability, IPSEY's ROE is +0.17%, compared to ESALF's ROE of +0.03%. Regarding short-term risk, IPSEY is less volatile compared to ESALF. This indicates potentially lower risk in terms of short-term price fluctuations for IPSEY.
IPSEY vs HKMPF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, HKMPF has a market cap of 6.2B. Regarding current trading prices, IPSEY is priced at $33.00, while HKMPF trades at $27.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas HKMPF's P/E ratio is 17.37. In terms of profitability, IPSEY's ROE is +0.17%, compared to HKMPF's ROE of +0.16%. Regarding short-term risk, IPSEY and HKMPF have similar daily volatility (0.00).
IPSEY vs HKMPY Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, HKMPY has a market cap of 6.1B. Regarding current trading prices, IPSEY is priced at $33.00, while HKMPY trades at $55.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas HKMPY's P/E ratio is 17.08. In terms of profitability, IPSEY's ROE is +0.17%, compared to HKMPY's ROE of +0.16%. Regarding short-term risk, IPSEY is less volatile compared to HKMPY. This indicates potentially lower risk in terms of short-term price fluctuations for IPSEY.
IPSEY vs GZPHF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, GZPHF has a market cap of 5.9B. Regarding current trading prices, IPSEY is priced at $33.00, while GZPHF trades at $2.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas GZPHF's P/E ratio is 10.35. In terms of profitability, IPSEY's ROE is +0.17%, compared to GZPHF's ROE of +0.07%. Regarding short-term risk, IPSEY and GZPHF have similar daily volatility (0.00).
IPSEY vs SGFEF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, SGFEF has a market cap of 5.2B. Regarding current trading prices, IPSEY is priced at $33.00, while SGFEF trades at $114.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas SGFEF's P/E ratio is 24.75. In terms of profitability, IPSEY's ROE is +0.17%, compared to SGFEF's ROE of +0.11%. Regarding short-term risk, IPSEY is less volatile compared to SGFEF. This indicates potentially lower risk in terms of short-term price fluctuations for IPSEY.
IPSEY vs WIBFF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, WIBFF has a market cap of 5B. Regarding current trading prices, IPSEY is priced at $33.00, while WIBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas WIBFF's P/E ratio is -0.01. In terms of profitability, IPSEY's ROE is +0.17%, compared to WIBFF's ROE of +0.00%. Regarding short-term risk, IPSEY is less volatile compared to WIBFF. This indicates potentially lower risk in terms of short-term price fluctuations for IPSEY.
IPSEY vs HLBBF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, HLBBF has a market cap of 4.2B. Regarding current trading prices, IPSEY is priced at $33.00, while HLBBF trades at $5.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas HLBBF's P/E ratio is 10.25. In terms of profitability, IPSEY's ROE is +0.17%, compared to HLBBF's ROE of +0.14%. Regarding short-term risk, IPSEY and HLBBF have similar daily volatility (0.00).
IPSEY vs CHSYF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, CHSYF has a market cap of 3.7B. Regarding current trading prices, IPSEY is priced at $33.00, while CHSYF trades at $1.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas CHSYF's P/E ratio is 16.85. In terms of profitability, IPSEY's ROE is +0.17%, compared to CHSYF's ROE of +0.09%. Regarding short-term risk, IPSEY and CHSYF have similar daily volatility (0.00).
IPSEY vs LVZPF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, LVZPF has a market cap of 3.5B. Regarding current trading prices, IPSEY is priced at $33.00, while LVZPF trades at $3.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas LVZPF's P/E ratio is 11.43. In terms of profitability, IPSEY's ROE is +0.17%, compared to LVZPF's ROE of +0.15%. Regarding short-term risk, IPSEY is less volatile compared to LVZPF. This indicates potentially lower risk in terms of short-term price fluctuations for IPSEY.
IPSEY vs HLUBF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, HLUBF has a market cap of 3.4B. Regarding current trading prices, IPSEY is priced at $33.00, while HLUBF trades at $3.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas HLUBF's P/E ratio is 7.12. In terms of profitability, IPSEY's ROE is +0.17%, compared to HLUBF's ROE of +0.14%. Regarding short-term risk, IPSEY is less volatile compared to HLUBF. This indicates potentially lower risk in terms of short-term price fluctuations for IPSEY.
IPSEY vs ULIHF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, ULIHF has a market cap of 3.4B. Regarding current trading prices, IPSEY is priced at $33.00, while ULIHF trades at $1.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas ULIHF's P/E ratio is 9.25. In terms of profitability, IPSEY's ROE is +0.17%, compared to ULIHF's ROE of +0.21%. Regarding short-term risk, IPSEY and ULIHF have similar daily volatility (0.00).
IPSEY vs APNHF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, APNHF has a market cap of 3.2B. Regarding current trading prices, IPSEY is priced at $33.00, while APNHF trades at $7.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas APNHF's P/E ratio is 12.72. In terms of profitability, IPSEY's ROE is +0.17%, compared to APNHF's ROE of +0.04%. Regarding short-term risk, IPSEY is less volatile compared to APNHF. This indicates potentially lower risk in terms of short-term price fluctuations for IPSEY.
IPSEY vs APNHY Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, APNHY has a market cap of 3.1B. Regarding current trading prices, IPSEY is priced at $33.00, while APNHY trades at $6.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas APNHY's P/E ratio is 12.43. In terms of profitability, IPSEY's ROE is +0.17%, compared to APNHY's ROE of +0.05%. Regarding short-term risk, IPSEY is less volatile compared to APNHY. This indicates potentially lower risk in terms of short-term price fluctuations for IPSEY.
IPSEY vs SMDPY Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, SMDPY has a market cap of 3.1B. Regarding current trading prices, IPSEY is priced at $33.00, while SMDPY trades at $7.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas SMDPY's P/E ratio is 19.42. In terms of profitability, IPSEY's ROE is +0.17%, compared to SMDPY's ROE of +0.15%. Regarding short-term risk, IPSEY and SMDPY have similar daily volatility (0.00).
IPSEY vs HYPMY Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, HYPMY has a market cap of 3.1B. Regarding current trading prices, IPSEY is priced at $33.00, while HYPMY trades at $4.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas HYPMY's P/E ratio is 21.17. In terms of profitability, IPSEY's ROE is +0.17%, compared to HYPMY's ROE of +0.07%. Regarding short-term risk, IPSEY is less volatile compared to HYPMY. This indicates potentially lower risk in terms of short-term price fluctuations for IPSEY.
IPSEY vs INVVY Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, INVVY has a market cap of 3B. Regarding current trading prices, IPSEY is priced at $33.00, while INVVY trades at $21.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas INVVY's P/E ratio is -62.42. In terms of profitability, IPSEY's ROE is +0.17%, compared to INVVY's ROE of -0.01%. Regarding short-term risk, IPSEY and INVVY have similar daily volatility (0.00).
IPSEY vs IZQVF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, IZQVF has a market cap of 2.9B. Regarding current trading prices, IPSEY is priced at $33.00, while IZQVF trades at $20.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas IZQVF's P/E ratio is -56.68. In terms of profitability, IPSEY's ROE is +0.17%, compared to IZQVF's ROE of -0.01%. Regarding short-term risk, IPSEY and IZQVF have similar daily volatility (0.00).
IPSEY vs DNPUF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, DNPUF has a market cap of 2.9B. Regarding current trading prices, IPSEY is priced at $33.00, while DNPUF trades at $7.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas DNPUF's P/E ratio is 18.10. In terms of profitability, IPSEY's ROE is +0.17%, compared to DNPUF's ROE of +0.15%. Regarding short-term risk, IPSEY is less volatile compared to DNPUF. This indicates potentially lower risk in terms of short-term price fluctuations for IPSEY.
IPSEY vs LBTSF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, LBTSF has a market cap of 2.9B. Regarding current trading prices, IPSEY is priced at $33.00, while LBTSF trades at $13.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas LBTSF's P/E ratio is 102.77. In terms of profitability, IPSEY's ROE is +0.17%, compared to LBTSF's ROE of +0.02%. Regarding short-term risk, IPSEY and LBTSF have similar daily volatility (0.00).
IPSEY vs HMDCF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, HMDCF has a market cap of 2.8B. Regarding current trading prices, IPSEY is priced at $33.00, while HMDCF trades at $3.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas HMDCF's P/E ratio is -64.10. In terms of profitability, IPSEY's ROE is +0.17%, compared to HMDCF's ROE of -0.01%. Regarding short-term risk, IPSEY is less volatile compared to HMDCF. This indicates potentially lower risk in terms of short-term price fluctuations for IPSEY.
IPSEY vs THCBF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, THCBF has a market cap of 2.4B. Regarding current trading prices, IPSEY is priced at $33.00, while THCBF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas THCBF's P/E ratio is -0.10. In terms of profitability, IPSEY's ROE is +0.17%, compared to THCBF's ROE of +0.00%. Regarding short-term risk, IPSEY is less volatile compared to THCBF. This indicates potentially lower risk in terms of short-term price fluctuations for IPSEY.
IPSEY vs DMPHF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, DMPHF has a market cap of 2.1B. Regarding current trading prices, IPSEY is priced at $33.00, while DMPHF trades at $39.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas DMPHF's P/E ratio is 17.90. In terms of profitability, IPSEY's ROE is +0.17%, compared to DMPHF's ROE of +0.17%. Regarding short-term risk, IPSEY is less volatile compared to DMPHF. This indicates potentially lower risk in terms of short-term price fluctuations for IPSEY.
IPSEY vs HTSUF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, HTSUF has a market cap of 2.1B. Regarding current trading prices, IPSEY is priced at $33.00, while HTSUF trades at $28.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas HTSUF's P/E ratio is 16.17. In terms of profitability, IPSEY's ROE is +0.17%, compared to HTSUF's ROE of +0.08%. Regarding short-term risk, IPSEY is less volatile compared to HTSUF. This indicates potentially lower risk in terms of short-term price fluctuations for IPSEY.
IPSEY vs LJUIF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, LJUIF has a market cap of 2.1B. Regarding current trading prices, IPSEY is priced at $33.00, while LJUIF trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas LJUIF's P/E ratio is 13.97. In terms of profitability, IPSEY's ROE is +0.17%, compared to LJUIF's ROE of +0.19%. Regarding short-term risk, IPSEY and LJUIF have similar daily volatility (0.00).
IPSEY vs ARSUF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, ARSUF has a market cap of 1.8B. Regarding current trading prices, IPSEY is priced at $33.00, while ARSUF trades at $25.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas ARSUF's P/E ratio is 22.70. In terms of profitability, IPSEY's ROE is +0.17%, compared to ARSUF's ROE of +0.16%. Regarding short-term risk, IPSEY and ARSUF have similar daily volatility (0.00).
IPSEY vs TSMRF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, TSMRF has a market cap of 1.8B. Regarding current trading prices, IPSEY is priced at $33.00, while TSMRF trades at $23.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas TSMRF's P/E ratio is 8.19. In terms of profitability, IPSEY's ROE is +0.17%, compared to TSMRF's ROE of +0.11%. Regarding short-term risk, IPSEY and TSMRF have similar daily volatility (0.00).
IPSEY vs NPNKF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, NPNKF has a market cap of 1.7B. Regarding current trading prices, IPSEY is priced at $33.00, while NPNKF trades at $25.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas NPNKF's P/E ratio is 7.85. In terms of profitability, IPSEY's ROE is +0.17%, compared to NPNKF's ROE of +0.14%. Regarding short-term risk, IPSEY is less volatile compared to NPNKF. This indicates potentially lower risk in terms of short-term price fluctuations for IPSEY.
IPSEY vs MITPF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, MITPF has a market cap of 1.6B. Regarding current trading prices, IPSEY is priced at $33.00, while MITPF trades at $23.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas MITPF's P/E ratio is -10.81. In terms of profitability, IPSEY's ROE is +0.17%, compared to MITPF's ROE of +4.92%. Regarding short-term risk, IPSEY is less volatile compared to MITPF. This indicates potentially lower risk in terms of short-term price fluctuations for IPSEY.
IPSEY vs KARBF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, KARBF has a market cap of 1.5B. Regarding current trading prices, IPSEY is priced at $33.00, while KARBF trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas KARBF's P/E ratio is 262.50. In terms of profitability, IPSEY's ROE is +0.17%, compared to KARBF's ROE of N/A. Regarding short-term risk, IPSEY and KARBF have similar daily volatility (0.00).
IPSEY vs EVOTF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, EVOTF has a market cap of 1.5B. Regarding current trading prices, IPSEY is priced at $33.00, while EVOTF trades at $8.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas EVOTF's P/E ratio is -6.26. In terms of profitability, IPSEY's ROE is +0.17%, compared to EVOTF's ROE of -0.22%. Regarding short-term risk, IPSEY is less volatile compared to EVOTF. This indicates potentially lower risk in terms of short-term price fluctuations for IPSEY.
IPSEY vs CASBF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, CASBF has a market cap of 1.5B. Regarding current trading prices, IPSEY is priced at $33.00, while CASBF trades at $4.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas CASBF's P/E ratio is -23.33. In terms of profitability, IPSEY's ROE is +0.17%, compared to CASBF's ROE of -0.14%. Regarding short-term risk, IPSEY is less volatile compared to CASBF. This indicates potentially lower risk in terms of short-term price fluctuations for IPSEY.
IPSEY vs SHEZF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, SHEZF has a market cap of 1.4B. Regarding current trading prices, IPSEY is priced at $33.00, while SHEZF trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas SHEZF's P/E ratio is -23.48. In terms of profitability, IPSEY's ROE is +0.17%, compared to SHEZF's ROE of +0.05%. Regarding short-term risk, IPSEY and SHEZF have similar daily volatility (0.00).
IPSEY vs NPPNY Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, NPPNY has a market cap of 1.4B. Regarding current trading prices, IPSEY is priced at $33.00, while NPPNY trades at $5.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas NPPNY's P/E ratio is 6.59. In terms of profitability, IPSEY's ROE is +0.17%, compared to NPPNY's ROE of +0.09%. Regarding short-term risk, IPSEY and NPPNY have similar daily volatility (0.00).
IPSEY vs CHIZF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, CHIZF has a market cap of 1.4B. Regarding current trading prices, IPSEY is priced at $33.00, while CHIZF trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas CHIZF's P/E ratio is 13.75. In terms of profitability, IPSEY's ROE is +0.17%, compared to CHIZF's ROE of +0.04%. Regarding short-term risk, IPSEY and CHIZF have similar daily volatility (0.00).
IPSEY vs GTBIF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, GTBIF has a market cap of 1.4B. Regarding current trading prices, IPSEY is priced at $33.00, while GTBIF trades at $5.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas GTBIF's P/E ratio is 27.71. In terms of profitability, IPSEY's ROE is +0.17%, compared to GTBIF's ROE of +0.03%. Regarding short-term risk, IPSEY is less volatile compared to GTBIF. This indicates potentially lower risk in terms of short-term price fluctuations for IPSEY.
IPSEY vs SWGHF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, SWGHF has a market cap of 1.1B. Regarding current trading prices, IPSEY is priced at $33.00, while SWGHF trades at $11.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas SWGHF's P/E ratio is 15.57. In terms of profitability, IPSEY's ROE is +0.17%, compared to SWGHF's ROE of +0.12%. Regarding short-term risk, IPSEY and SWGHF have similar daily volatility (0.00).
IPSEY vs KSPHF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, KSPHF has a market cap of 1.1B. Regarding current trading prices, IPSEY is priced at $33.00, while KSPHF trades at $27.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas KSPHF's P/E ratio is 14.66. In terms of profitability, IPSEY's ROE is +0.17%, compared to KSPHF's ROE of +0.06%. Regarding short-term risk, IPSEY and KSPHF have similar daily volatility (0.00).
IPSEY vs GNMLF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, GNMLF has a market cap of 1.1B. Regarding current trading prices, IPSEY is priced at $33.00, while GNMLF trades at $1.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas GNMLF's P/E ratio is 9.08. In terms of profitability, IPSEY's ROE is +0.17%, compared to GNMLF's ROE of +0.12%. Regarding short-term risk, IPSEY and GNMLF have similar daily volatility (0.00).
IPSEY vs KKPCF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, KKPCF has a market cap of 1B. Regarding current trading prices, IPSEY is priced at $33.00, while KKPCF trades at $28.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas KKPCF's P/E ratio is 11.33. In terms of profitability, IPSEY's ROE is +0.17%, compared to KKPCF's ROE of +0.09%. Regarding short-term risk, IPSEY is less volatile compared to KKPCF. This indicates potentially lower risk in terms of short-term price fluctuations for IPSEY.
IPSEY vs CURLF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, CURLF has a market cap of 963.2M. Regarding current trading prices, IPSEY is priced at $33.00, while CURLF trades at $1.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas CURLF's P/E ratio is -3.82. In terms of profitability, IPSEY's ROE is +0.17%, compared to CURLF's ROE of -0.25%. Regarding short-term risk, IPSEY is less volatile compared to CURLF. This indicates potentially lower risk in terms of short-term price fluctuations for IPSEY.
IPSEY vs BIOGY Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, BIOGY has a market cap of 960.3M. Regarding current trading prices, IPSEY is priced at $33.00, while BIOGY trades at $9.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas BIOGY's P/E ratio is 32.50. In terms of profitability, IPSEY's ROE is +0.17%, compared to BIOGY's ROE of +0.18%. Regarding short-term risk, IPSEY and BIOGY have similar daily volatility (0.00).
IPSEY vs SHPHF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, SHPHF has a market cap of 924.4M. Regarding current trading prices, IPSEY is priced at $33.00, while SHPHF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas SHPHF's P/E ratio is -3.33. In terms of profitability, IPSEY's ROE is +0.17%, compared to SHPHF's ROE of -0.01%. Regarding short-term risk, IPSEY is less volatile compared to SHPHF. This indicates potentially lower risk in terms of short-term price fluctuations for IPSEY.
IPSEY vs LVTTF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, LVTTF has a market cap of 901.7M. Regarding current trading prices, IPSEY is priced at $33.00, while LVTTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas LVTTF's P/E ratio is -0.02. In terms of profitability, IPSEY's ROE is +0.17%, compared to LVTTF's ROE of +0.00%. Regarding short-term risk, IPSEY is less volatile compared to LVTTF. This indicates potentially lower risk in terms of short-term price fluctuations for IPSEY.
IPSEY vs EVRRF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, EVRRF has a market cap of 897.8M. Regarding current trading prices, IPSEY is priced at $33.00, while EVRRF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas EVRRF's P/E ratio is -0.08. In terms of profitability, IPSEY's ROE is +0.17%, compared to EVRRF's ROE of +2.97%. Regarding short-term risk, IPSEY and EVRRF have similar daily volatility (0.00).
IPSEY vs TCNNF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, TCNNF has a market cap of 863.9M. Regarding current trading prices, IPSEY is priced at $33.00, while TCNNF trades at $4.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas TCNNF's P/E ratio is -5.72. In terms of profitability, IPSEY's ROE is +0.17%, compared to TCNNF's ROE of -0.13%. Regarding short-term risk, IPSEY is less volatile compared to TCNNF. This indicates potentially lower risk in terms of short-term price fluctuations for IPSEY.
IPSEY vs NRXCF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, NRXCF has a market cap of 851.8M. Regarding current trading prices, IPSEY is priced at $33.00, while NRXCF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas NRXCF's P/E ratio is -0.22. In terms of profitability, IPSEY's ROE is +0.17%, compared to NRXCF's ROE of +2.32%. Regarding short-term risk, IPSEY and NRXCF have similar daily volatility (0.00).
IPSEY vs TWAPF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, TWAPF has a market cap of 828.5M. Regarding current trading prices, IPSEY is priced at $33.00, while TWAPF trades at $16.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas TWAPF's P/E ratio is 6.28. In terms of profitability, IPSEY's ROE is +0.17%, compared to TWAPF's ROE of +0.11%. Regarding short-term risk, IPSEY and TWAPF have similar daily volatility (0.00).
IPSEY vs SWDCF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, SWDCF has a market cap of 773.6M. Regarding current trading prices, IPSEY is priced at $33.00, while SWDCF trades at $4.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas SWDCF's P/E ratio is 121.00. In terms of profitability, IPSEY's ROE is +0.17%, compared to SWDCF's ROE of +0.01%. Regarding short-term risk, IPSEY is less volatile compared to SWDCF. This indicates potentially lower risk in terms of short-term price fluctuations for IPSEY.
IPSEY vs CSWYF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, CSWYF has a market cap of 758.4M. Regarding current trading prices, IPSEY is priced at $33.00, while CSWYF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas CSWYF's P/E ratio is 4.78. In terms of profitability, IPSEY's ROE is +0.17%, compared to CSWYF's ROE of +0.07%. Regarding short-term risk, IPSEY is less volatile compared to CSWYF. This indicates potentially lower risk in terms of short-term price fluctuations for IPSEY.
IPSEY vs NIKA Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, NIKA has a market cap of 708.2M. Regarding current trading prices, IPSEY is priced at $33.00, while NIKA trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas NIKA's P/E ratio is N/A. In terms of profitability, IPSEY's ROE is +0.17%, compared to NIKA's ROE of +0.39%. Regarding short-term risk, IPSEY and NIKA have similar daily volatility (0.00).
IPSEY vs TRXPF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, TRXPF has a market cap of 690.7M. Regarding current trading prices, IPSEY is priced at $33.00, while TRXPF trades at $24.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas TRXPF's P/E ratio is 25.86. In terms of profitability, IPSEY's ROE is +0.17%, compared to TRXPF's ROE of +0.04%. Regarding short-term risk, IPSEY and TRXPF have similar daily volatility (0.00).
IPSEY vs YIHCF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, YIHCF has a market cap of 643.1M. Regarding current trading prices, IPSEY is priced at $33.00, while YIHCF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas YIHCF's P/E ratio is -5.00. In terms of profitability, IPSEY's ROE is +0.17%, compared to YIHCF's ROE of +0.19%. Regarding short-term risk, IPSEY and YIHCF have similar daily volatility (0.00).
IPSEY vs TRSSF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, TRSSF has a market cap of 601.9M. Regarding current trading prices, IPSEY is priced at $33.00, while TRSSF trades at $1.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas TRSSF's P/E ratio is -1.32. In terms of profitability, IPSEY's ROE is +0.17%, compared to TRSSF's ROE of -0.32%. Regarding short-term risk, IPSEY is less volatile compared to TRSSF. This indicates potentially lower risk in terms of short-term price fluctuations for IPSEY.
IPSEY vs ELTP Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, ELTP has a market cap of 580.4M. Regarding current trading prices, IPSEY is priced at $33.00, while ELTP trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas ELTP's P/E ratio is -27.10. In terms of profitability, IPSEY's ROE is +0.17%, compared to ELTP's ROE of -0.09%. Regarding short-term risk, IPSEY is less volatile compared to ELTP. This indicates potentially lower risk in terms of short-term price fluctuations for IPSEY.
IPSEY vs AIHLF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, AIHLF has a market cap of 566M. Regarding current trading prices, IPSEY is priced at $33.00, while AIHLF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas AIHLF's P/E ratio is 12.07. In terms of profitability, IPSEY's ROE is +0.17%, compared to AIHLF's ROE of +0.15%. Regarding short-term risk, IPSEY and AIHLF have similar daily volatility (0.00).
IPSEY vs PKBFF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, PKBFF has a market cap of 550.7M. Regarding current trading prices, IPSEY is priced at $33.00, while PKBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas PKBFF's P/E ratio is N/A. In terms of profitability, IPSEY's ROE is +0.17%, compared to PKBFF's ROE of +7.96%. Regarding short-term risk, IPSEY and PKBFF have similar daily volatility (0.00).
IPSEY vs CCHWF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, CCHWF has a market cap of 521.3M. Regarding current trading prices, IPSEY is priced at $33.00, while CCHWF trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas CCHWF's P/E ratio is -1.12. In terms of profitability, IPSEY's ROE is +0.17%, compared to CCHWF's ROE of -7.05%. Regarding short-term risk, IPSEY is less volatile compared to CCHWF. This indicates potentially lower risk in terms of short-term price fluctuations for IPSEY.
IPSEY vs BOIRF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, BOIRF has a market cap of 494.8M. Regarding current trading prices, IPSEY is priced at $33.00, while BOIRF trades at $28.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas BOIRF's P/E ratio is 20.07. In terms of profitability, IPSEY's ROE is +0.17%, compared to BOIRF's ROE of +0.06%. Regarding short-term risk, IPSEY is less volatile compared to BOIRF. This indicates potentially lower risk in terms of short-term price fluctuations for IPSEY.
IPSEY vs PEXXF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, PEXXF has a market cap of 463.1M. Regarding current trading prices, IPSEY is priced at $33.00, while PEXXF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas PEXXF's P/E ratio is 9.00. In terms of profitability, IPSEY's ROE is +0.17%, compared to PEXXF's ROE of N/A. Regarding short-term risk, IPSEY and PEXXF have similar daily volatility (0.00).
IPSEY vs KHTRF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, KHTRF has a market cap of 448.4M. Regarding current trading prices, IPSEY is priced at $33.00, while KHTRF trades at $4.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas KHTRF's P/E ratio is 64.29. In terms of profitability, IPSEY's ROE is +0.17%, compared to KHTRF's ROE of +0.01%. Regarding short-term risk, IPSEY is less volatile compared to KHTRF. This indicates potentially lower risk in terms of short-term price fluctuations for IPSEY.
IPSEY vs AGYTF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, AGYTF has a market cap of 405.1M. Regarding current trading prices, IPSEY is priced at $33.00, while AGYTF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas AGYTF's P/E ratio is -8.50. In terms of profitability, IPSEY's ROE is +0.17%, compared to AGYTF's ROE of -2.67%. Regarding short-term risk, IPSEY is less volatile compared to AGYTF. This indicates potentially lower risk in terms of short-term price fluctuations for IPSEY.
IPSEY vs HUMDF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, HUMDF has a market cap of 404M. Regarding current trading prices, IPSEY is priced at $33.00, while HUMDF trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas HUMDF's P/E ratio is -13.69. In terms of profitability, IPSEY's ROE is +0.17%, compared to HUMDF's ROE of +8.06%. Regarding short-term risk, IPSEY and HUMDF have similar daily volatility (0.00).
IPSEY vs BHCCF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, BHCCF has a market cap of 271.6M. Regarding current trading prices, IPSEY is priced at $33.00, while BHCCF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas BHCCF's P/E ratio is -4.57. In terms of profitability, IPSEY's ROE is +0.17%, compared to BHCCF's ROE of +0.19%. Regarding short-term risk, IPSEY is less volatile compared to BHCCF. This indicates potentially lower risk in terms of short-term price fluctuations for IPSEY.
IPSEY vs GLASF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, GLASF has a market cap of 269.1M. Regarding current trading prices, IPSEY is priced at $33.00, while GLASF trades at $5.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas GLASF's P/E ratio is -57.67. In terms of profitability, IPSEY's ROE is +0.17%, compared to GLASF's ROE of +0.07%. Regarding short-term risk, IPSEY is less volatile compared to GLASF. This indicates potentially lower risk in terms of short-term price fluctuations for IPSEY.
IPSEY vs CPHRF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, CPHRF has a market cap of 233.8M. Regarding current trading prices, IPSEY is priced at $33.00, while CPHRF trades at $9.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas CPHRF's P/E ratio is 25.34. In terms of profitability, IPSEY's ROE is +0.17%, compared to CPHRF's ROE of +0.09%. Regarding short-term risk, IPSEY is less volatile compared to CPHRF. This indicates potentially lower risk in terms of short-term price fluctuations for IPSEY.
IPSEY vs CRLBF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, CRLBF has a market cap of 212.3M. Regarding current trading prices, IPSEY is priced at $33.00, while CRLBF trades at $0.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas CRLBF's P/E ratio is -2.62. In terms of profitability, IPSEY's ROE is +0.17%, compared to CRLBF's ROE of -0.18%. Regarding short-term risk, IPSEY is less volatile compared to CRLBF. This indicates potentially lower risk in terms of short-term price fluctuations for IPSEY.
IPSEY vs VRNOF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, VRNOF has a market cap of 209M. Regarding current trading prices, IPSEY is priced at $33.00, while VRNOF trades at $0.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas VRNOF's P/E ratio is -0.58. In terms of profitability, IPSEY's ROE is +0.17%, compared to VRNOF's ROE of -0.22%. Regarding short-term risk, IPSEY is less volatile compared to VRNOF. This indicates potentially lower risk in terms of short-term price fluctuations for IPSEY.
IPSEY vs PLNHF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, PLNHF has a market cap of 202M. Regarding current trading prices, IPSEY is priced at $33.00, while PLNHF trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas PLNHF's P/E ratio is -3.50. In terms of profitability, IPSEY's ROE is +0.17%, compared to PLNHF's ROE of -0.34%. Regarding short-term risk, IPSEY is less volatile compared to PLNHF. This indicates potentially lower risk in terms of short-term price fluctuations for IPSEY.
IPSEY vs PHCUF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, PHCUF has a market cap of 159.9M. Regarding current trading prices, IPSEY is priced at $33.00, while PHCUF trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas PHCUF's P/E ratio is 600.00. In terms of profitability, IPSEY's ROE is +0.17%, compared to PHCUF's ROE of +0.00%. Regarding short-term risk, IPSEY and PHCUF have similar daily volatility (0.00).
IPSEY vs CBWTF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, CBWTF has a market cap of 144M. Regarding current trading prices, IPSEY is priced at $33.00, while CBWTF trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas CBWTF's P/E ratio is 5.39. In terms of profitability, IPSEY's ROE is +0.17%, compared to CBWTF's ROE of -0.15%. Regarding short-term risk, IPSEY is less volatile compared to CBWTF. This indicates potentially lower risk in terms of short-term price fluctuations for IPSEY.
IPSEY vs COPHF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, COPHF has a market cap of 131.7M. Regarding current trading prices, IPSEY is priced at $33.00, while COPHF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas COPHF's P/E ratio is -0.02. In terms of profitability, IPSEY's ROE is +0.17%, compared to COPHF's ROE of -5.75%. Regarding short-term risk, IPSEY is less volatile compared to COPHF. This indicates potentially lower risk in terms of short-term price fluctuations for IPSEY.
IPSEY vs STMH Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, STMH has a market cap of 127.1M. Regarding current trading prices, IPSEY is priced at $33.00, while STMH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas STMH's P/E ratio is N/A. In terms of profitability, IPSEY's ROE is +0.17%, compared to STMH's ROE of -2.75%. Regarding short-term risk, IPSEY is less volatile compared to STMH. This indicates potentially lower risk in terms of short-term price fluctuations for IPSEY.
IPSEY vs NWPN Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, NWPN has a market cap of 123.7M. Regarding current trading prices, IPSEY is priced at $33.00, while NWPN trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas NWPN's P/E ratio is -0.04. In terms of profitability, IPSEY's ROE is +0.17%, compared to NWPN's ROE of +0.13%. Regarding short-term risk, IPSEY is less volatile compared to NWPN. This indicates potentially lower risk in terms of short-term price fluctuations for IPSEY.
IPSEY vs LOVFF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, LOVFF has a market cap of 120.1M. Regarding current trading prices, IPSEY is priced at $33.00, while LOVFF trades at $1.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas LOVFF's P/E ratio is 13.14. In terms of profitability, IPSEY's ROE is +0.17%, compared to LOVFF's ROE of +0.15%. Regarding short-term risk, IPSEY is less volatile compared to LOVFF. This indicates potentially lower risk in terms of short-term price fluctuations for IPSEY.
IPSEY vs HLTRF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, HLTRF has a market cap of 113.3M. Regarding current trading prices, IPSEY is priced at $33.00, while HLTRF trades at $3.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas HLTRF's P/E ratio is -6.32. In terms of profitability, IPSEY's ROE is +0.17%, compared to HLTRF's ROE of -0.24%. Regarding short-term risk, IPSEY and HLTRF have similar daily volatility (0.00).
IPSEY vs LPCUF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, LPCUF has a market cap of 110.8M. Regarding current trading prices, IPSEY is priced at $33.00, while LPCUF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas LPCUF's P/E ratio is 18.82. In terms of profitability, IPSEY's ROE is +0.17%, compared to LPCUF's ROE of +0.05%. Regarding short-term risk, IPSEY is less volatile compared to LPCUF. This indicates potentially lower risk in terms of short-term price fluctuations for IPSEY.
IPSEY vs CNVCF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, CNVCF has a market cap of 109.2M. Regarding current trading prices, IPSEY is priced at $33.00, while CNVCF trades at $6.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas CNVCF's P/E ratio is -5.00. In terms of profitability, IPSEY's ROE is +0.17%, compared to CNVCF's ROE of +9.56%. Regarding short-term risk, IPSEY and CNVCF have similar daily volatility (0.00).
IPSEY vs GRUSF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, GRUSF has a market cap of 99.2M. Regarding current trading prices, IPSEY is priced at $33.00, while GRUSF trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas GRUSF's P/E ratio is -13.34. In terms of profitability, IPSEY's ROE is +0.17%, compared to GRUSF's ROE of -0.89%. Regarding short-term risk, IPSEY is less volatile compared to GRUSF. This indicates potentially lower risk in terms of short-term price fluctuations for IPSEY.
IPSEY vs BIOYF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, BIOYF has a market cap of 96.9M. Regarding current trading prices, IPSEY is priced at $33.00, while BIOYF trades at $8.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas BIOYF's P/E ratio is 17.24. In terms of profitability, IPSEY's ROE is +0.17%, compared to BIOYF's ROE of +0.22%. Regarding short-term risk, IPSEY and BIOYF have similar daily volatility (0.00).
IPSEY vs JUSHF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, JUSHF has a market cap of 88.5M. Regarding current trading prices, IPSEY is priced at $33.00, while JUSHF trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas JUSHF's P/E ratio is -1.80. In terms of profitability, IPSEY's ROE is +0.17%, compared to JUSHF's ROE of +1.06%. Regarding short-term risk, IPSEY is less volatile compared to JUSHF. This indicates potentially lower risk in terms of short-term price fluctuations for IPSEY.
IPSEY vs LRDSF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, LRDSF has a market cap of 84.9M. Regarding current trading prices, IPSEY is priced at $33.00, while LRDSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas LRDSF's P/E ratio is -0.01. In terms of profitability, IPSEY's ROE is +0.17%, compared to LRDSF's ROE of +1.61%. Regarding short-term risk, IPSEY is less volatile compared to LRDSF. This indicates potentially lower risk in terms of short-term price fluctuations for IPSEY.
IPSEY vs AAWH Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, AAWH has a market cap of 83.4M. Regarding current trading prices, IPSEY is priced at $33.00, while AAWH trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas AAWH's P/E ratio is -1.02. In terms of profitability, IPSEY's ROE is +0.17%, compared to AAWH's ROE of -1.05%. Regarding short-term risk, IPSEY is less volatile compared to AAWH. This indicates potentially lower risk in terms of short-term price fluctuations for IPSEY.
IPSEY vs ABSCF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, ABSCF has a market cap of 77.4M. Regarding current trading prices, IPSEY is priced at $33.00, while ABSCF trades at $1.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas ABSCF's P/E ratio is -7.41. In terms of profitability, IPSEY's ROE is +0.17%, compared to ABSCF's ROE of +0.32%. Regarding short-term risk, IPSEY is less volatile compared to ABSCF. This indicates potentially lower risk in terms of short-term price fluctuations for IPSEY.
IPSEY vs EOFBY Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, EOFBY has a market cap of 73.7M. Regarding current trading prices, IPSEY is priced at $33.00, while EOFBY trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas EOFBY's P/E ratio is -7.67. In terms of profitability, IPSEY's ROE is +0.17%, compared to EOFBY's ROE of N/A. Regarding short-term risk, IPSEY and EOFBY have similar daily volatility (0.00).
IPSEY vs DUTV Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, DUTV has a market cap of 71.8M. Regarding current trading prices, IPSEY is priced at $33.00, while DUTV trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas DUTV's P/E ratio is N/A. In terms of profitability, IPSEY's ROE is +0.17%, compared to DUTV's ROE of +0.02%. Regarding short-term risk, IPSEY is less volatile compared to DUTV. This indicates potentially lower risk in terms of short-term price fluctuations for IPSEY.
IPSEY vs ORXOF Comparison
IPSEY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IPSEY stands at 43.7B. In comparison, ORXOF has a market cap of 69.7M. Regarding current trading prices, IPSEY is priced at $33.00, while ORXOF trades at $2.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IPSEY currently has a P/E ratio of 26.61, whereas ORXOF's P/E ratio is -3.11. In terms of profitability, IPSEY's ROE is +0.17%, compared to ORXOF's ROE of +2.89%. Regarding short-term risk, IPSEY is less volatile compared to ORXOF. This indicates potentially lower risk in terms of short-term price fluctuations for IPSEY.